HIGHLIGHTS
- who: Wei Yi and Yao Xie from the Hamamatsu University School of Medicine, Japan have published the research: An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients, in the Journal: (JOURNAL)
- what: In this study, the effect of interferon intermittent therapy mode was analyzed. The study showed that 19.41% of patients achieved HBsAg disappearance and 14.14% achieved HBsAg seroconversion through initial, intermittent, and retreatment of PEG-IFNα.
- how: The results showed that only the baseline HBsAg in the retreatment period (OR 0.376 95 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.